fbpx Niemann–Pick disease type C in Palestine: genotype and phenotype of sixteen patients and report of a novel mutation in the NPC1 gene |ARAB AMERICAN UNIVERSITY
Contact information for Technical Support and Student Assistance ... Click here

Niemann–Pick disease type C in Palestine: genotype and phenotype of sixteen patients and report of a novel mutation in the NPC1 gene

Authors: 
Imad Dweikat1*, Othman Thaher2 , Abdulrahman Abosleem2 , Almotazbellah Zeer2 and Ameer Abo Mokh2
ISSN: 
1755-8794
Journal Name: 
BMC medical Genomics
Volume: 
14
Issue: 
228
Pages From: 
1
To: 
8
Date: 
Friday, September 17, 2021
Keywords: 
NPC, Vertical supranuclear gaze palsy, Hepatosplenomegaly, Founder mutation
Abstract: 
Background: Niemann–Pick disease type C (NPC) is an autosomal recessive, neurodegenerative disease caused by mutations in either the NPC1 or NPC2 genes. Mutations in these genes are associated with abnormal endosomal–lysosomal trafcking, resulting in the accumulation of tissue-specifc lipids in lysosomes. Methods: We described sixteen patients with NPC diagnosed between the age of 1 month and 30 years at two tertiary care centers in Palestine. The clinical phenotype, brain magnetic resonance imaging (MRI), and molecular genetic analysis data were reviewed. Results: The diagnosis was confrmed by molecular analysis in all patients. Fourteen out of sixteen patients were homozygous for the NPC1 p.G992W variant. Among them, most were categorized as having the late-infantile neurological form of disease onset. They predominantly manifested with early-onset visceral manifestations in the form of hepatosplenomegaly and prolonged neonatal jaundice, and late-onset neuropsychiatric manifestations in the form of vertical supranuclear gaze palsy (VSGP), ataxia, cognitive impairment and seizures. Brain MRI in 6 patients was normal in 5 or consistent with cerebellar hemisphere atrophy in 1 of them. Two other mutations were identifed in the NPC1 gene, of which p.V845Cfs*24 was novel. Conclusions: Our results revealed phenotypic heterogeneity of NPC even within the same genotype, and add to the increasingly recognized evidence that cholestatic jaundice and hepatosplenomegaly during infancy, should alert the physician for the possibility of NPC. We reported a novel mutation in the NPC1 gene further expanding its genotype. Keywords: NPC, Vertical supranuclear gaze palsy, Hepatosplenomegaly, Founder mutation